Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers

Journal of Pathology

Volumn 210, Issue 2, 2006, Pages 192-204

  Woenckhaus, Matthias ^a   Klein Hitpass, L ^b   Grepmeier, U ^a   Merk, J ^a   Pfeifer, M ^a   Wild, P J ^a   Bettstetter, M ^a   Wuensch, P ^c   Blaszyk, H ^d   Hartmann, A ^a   Hofstaedter, F ^a   Dietmaier, W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Municipal Hospitals of Nuemberg ^*  (Germany)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Benign bronchial epithelium; cDNA array; Gene expression; NSCLC; Smoker and non smoker

Indexed keywords

CELL PROTEIN; CIGARETTE SMOKE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MACROPHAGE ELASTASE; MUCIN 7; ONCOPROTEIN; OXIDOREDUCTASE; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN AKR1B10; PROTEIN AKR1C1; PROTEIN HLF; PROTEIN LMO3; PROTEIN MT1K; PROTEIN RTN1; PROTEIN SPRR1B; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER GENETICS; CANCER RISK; CELL DIFFERENTIATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS; LUNG NON SMALL CELL CANCER; MALE; MICROARRAY ANALYSIS; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VALIDATION PROCESS; XENOBIOTIC METABOLISM;

ADENOCARCINOMA; ADULT; AGED; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY ALVEOLI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING;

EID: 33749055937     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2039     Document Type: Article

References (55)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics. CA Cancer J Clin 2003;53:5-26.
2. Kerr KM. Pulmonary preinvasive neoplasia. J Clin Pathol 2001;54:257-271.
3. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, et al. Diversity of gene expression in adenocarcinorna, of the lung. Proc Natl Acad Sci U S A 2001;98:13784-13789.
4. Wigle DA, Jurisica 1, Radulovich N, Pintilie M, Rossant J, Liu N, et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 2002;62:3005-3008.
5. Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor. Chest 2002;121:6S-7S.
6. Petty RD, Nicolson MC, Keff KM, Collie-Duguid E, Murray GI. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 2004;10:3237-3248.
7. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-650.
8. Boyle JO, Lonardo F, Chang JH, Klimstra D, Rusch V, Dmitrovsky E. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Clin Cancer Res 2001;7:259-266.
9. Gatenby RA, Vincent TL. An evolutionary model of carcinogenesis. Cancer Res 2003;63:6212-6220.
10. Gazdar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst 1999;91:299-301.
11. Gebel S, Gerstmayer B, Bosio A, Haussmann HJ, Van Miert E, Muller T. Gene expression profiling in respiratory tissues from nats exposed to mainstream cigarette smoke. Carcinogenesis 2004;25:169-178.
12. Murray JI, Whitfield ML, Trinklein ND, Myers RM, Brown PO, Botstein D. Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell 2004;15: 2361-2374.
13. Spira A, Beane J, Shah V, Liu G, Schembri F, Yang X, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 2004;101: 10143-10148.
14. Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998;5:220-226.
15. Baugh LR, Hill AA, Brown EL, Hunter CP. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001;29:E29.
16. Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 2004;20:1464-1465.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289-300.
18. Bettstetter M, Woenckhaus M, Wild PJ, Ruemmele P, Blaszyk H, Hartmann A, et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumor grade in colorectal cancer. J Pathol 2005;205:606-614.
19. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003;201:204-212.
20. Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, et al. Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 1999;154:83-95.
21. Stoehr R, Wild P, Hartmann A. Lasermicrodissection - an important prerequisite for the molecular-genetic analysis of bladder cancer. Pathol Res Pract 2003;199:355-362.
22. Kendziorski CM, Zhang Y, Lan H, Attie AD. The efficiency of pooling mRNA in microarray experiments. Biostatistics 2003;4:465-477.
23. Yatabe Y, Kosaka T, Takahashi T, Mitsudomi T. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol 2005;29:633-639.
24. Liu D, Matzuk MM, Sung WK, Guo Q, Wang P, Wolgemuth DJ. Cyclin A1 is required for meiosis in the male mouse. Nature Genet 1998;20:377-380.
25. Kulartz M, Knippers R. The replicative regulator protein geminin on chromatin in the HeLa cell cycle. J Biol Chem 2004;279:41686-41694.
26. Kopp JL, Wilder PJ, Desler M, Kim JH, Hou J, Nowling T, et al. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. J Biol Chem 2004;279:19407-19420.
27. Chinami M, Yano Y, Yang X, Salahuddin S, Moriyama K, Shiroishi M, et al. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2. J Biol Chem 2005;280:17235-17242.
28. Hsieh SY, Hsieh PS, Chin CT, Chen WY. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004;23:9183-9189.
29. Lau D, Xue L, Hu R, Liaw T, Wu R, Reddy S. Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis. Am J Respir Cell Mol Biol 2000;22:92-96.
30. Lopez-Ferrer A, Curull V, Bafranco C, Garrido M, Lloreta J, Real FX, et al. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol 2001;24:22-29.
31. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, et al. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2004;116:584-591.
32. Lane D, Rutherford TJ, Taylor HS. HOXA10 expression in endometrial adenocarcinoma. Tumour Biol 2005;25:264-269.
33. Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 2001;21: 7749-7763.
34. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H, et al. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991;48:550-556.
35. Hyndman D, Flynn TG. The aldo-keto reductases and their role in cancer. Adv Exp Med Biol 1999;463:427-434.
36. Sladek NE, Kollander R, Sreerama L, Kiang DT. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother Pharmacol 2002;49:309-321.
37. Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L, et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 2003;22:1580-1588.
38. Solomon B, Birms D, Roselt P, Weibe LI, McArthur GA, Cullinane C, et al. Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging. Mol Cancer Ther 2005;4:1417-1422.
39. Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, et al. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers. Int J Oncol 2005;27:481-488.
40. Clegg N, Ferguson C, True LD, Arnold H, Moorman A, Quinn JE, et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate 2003;55:55-64.
41. Kato Y, Hirano T, Yoshida K, Yashima K, Akimoto S, Tsuji K, et al. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Lung Cancer 2005;48:323-330.
42. Thomas P, Khokha R, Shepherd FA, Feld R, Tsao MS. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J Pathol 2000;190:150-156.
43. Charalabopoulos K, Gogah A, Kostoula OK, Constantopoulos SH. Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol 2004;26:256-260.
44. Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, et al. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003;24:441-449.
45. Penning TM. AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin Cancer Res 2005;11:1687-1690.
46. Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, et al. Overexpression of the aldo-keto reductase family protein AKR1B1O is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 2005;11: 1776-1785.
47. Ryu SD, Yi HG, Cha YN, Kang JH, Kang JS, Jeon YC, et al. Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation. Life Sci 2004;75:2559-2572.
48. Aledo R, Zschocke J, Pie J, Mir C, Fiesel S, Mayatepek E, et al. Genetic basis of mitochondrial HMG-CoA synthase deficiency. Hum Genet 2001;109:19-23.
49. Daheron L, Brizard F, Millot F, Cividin M, Lacotte L, Guilhot F, et al. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype. Hematol J 2002;3:153-156.
50. Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, et al. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 2005;65:4587-4597.
51. Morita M, Oyama T, Kagawa N, Nakata S, Ono K, Sugaya M, et al, Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer. Front Biosci 2005;10:2319-2324.
52. Padilla CA, Bajalica S, Lagercrantz J, Hohngren A. The gene for human glutaredoxin (GLRX) is localized to human chromosome 5q14. Genomics 1996;32:455-457.
53. van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, et al. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders. Ear J Hum Genet 2002;10:819-824.
54. Moscow JA, Schmidt L, Ingram DT, Gnarra J, Johnson B, Cowan KH. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 1994;15:2769-2773.
55. Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res 1999;59:2981-2988.